Tag Archives: SCH 900776 small molecule kinase inhibitor

Background Full Response (CR) at the primary tumor site as assessed

Background Full Response (CR) at the primary tumor site as assessed by clinical examination following induction chemotherapy with cisPlatin and 5-Fluorouracil (5-FU)[PF] is a favorable predictive factor for overall survival and disease-control in patients with locally advanced squamous cell carcinoma … Continue reading

Posted in Main | Tagged , | Comments Off on Background Full Response (CR) at the primary tumor site as assessed